| Date Filed | Type | Description |
| 03/14/2023 |
4
| WEST MICHAEL D (CEO) has filed a Form 4 on AgeX Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,060 shares
@ $0.59, valued at
$625.4
Exercised 3,125 restricted stock units
@ $0 |
|
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2022 |
4
| WEST MICHAEL D (CEO) has filed a Form 4 on AgeX Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,081 shares
@ $0.5623, valued at
$607.8
Exercised 3,125 restricted stock units
@ $0 |
|
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2022 |
4
| WEST MICHAEL D (CEO) has filed a Form 4 on AgeX Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,281 shares
@ $0.6923, valued at
$886.8
Exercised 3,125 restricted stock units
@ $0 |
|
| 12/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2020 |
4
| WEST MICHAEL D (CEO) has filed a Form 4 on AgeX Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,081 shares
@ $1.69, valued at
$1.8k
Exercised 3,125 restricted stock units
@ $0 |
|
| 09/15/2020 |
4
| WEST MICHAEL D (CEO) has filed a Form 4 on AgeX Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,081 shares
@ $0.8095, valued at
$875.1
Exercised 3,125 restricted stock units
@ $0 |
|
| 06/15/2020 |
4
| WEST MICHAEL D (CEO) has filed a Form 4 on AgeX Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,081 shares
@ $0.8001, valued at
$864.9
Exercised 3,125 restricted stock units
@ $0 |
|
| 03/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/13/2019 |
4
| WEST MICHAEL D (CEO) has filed a Form 4 on AgeX Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $4.28, valued at
$428k
Granted 50,000 restricted stock units
@ $0 |
|
| 02/14/2019 |
5
| WEST MICHAEL D (CEO) has filed a Form 5 on AgeX Therapeutics, Inc. |
| 12/12/2018 |
4
| WEST MICHAEL D (CEO) has filed a Form 4 on AgeX Therapeutics, Inc.|
Txns:
| Bought 4,000 shares
@ $3.8607, valued at
$15.4k
|
|
| 11/27/2018 |
3
| WEST MICHAEL D (CEO) has filed a Form 3 on AgeX Therapeutics, Inc. |
| 09/19/2018 |
4
| WEST MICHAEL D (Co-CEO) has filed a Form 4 on BIOTIME INC|
Txns:
| Paid exercise price by delivering 3,783 shares
@ $2.31, valued at
$8.7k
Exercised 10,938 restricted stock units
@ $0 |
|
| 07/12/2018 |
4
| WEST MICHAEL D (Co-CEO) has filed a Form 4 on BIOTIME INC|
Txns:
| Paid exercise price by delivering 541 shares
@ $2.2, valued at
$1.2k
Exercised 1,562 restricted stock units
@ $0 |
|
| 04/12/2018 |
4
| WEST MICHAEL D (Co-CEO) has filed a Form 4 on BIOTIME INC|
Txns:
| Paid exercise price by delivering 541 shares
@ $2.49, valued at
$1.3k
Exercised 1,563 restricted stock units
@ $0 |
|
| 01/12/2018 |
4
| WEST MICHAEL D (Co-CEO) has filed a Form 4 on BIOTIME INC|
Txns:
| Paid exercise price by delivering 686 shares
@ $2.68, valued at
$1.8k
Exercised 1,562 restricted stock units
@ $0 |
|
| 10/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/11/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/22/2013 |
4
| WEST MICHAEL D (CEO) has filed a Form 4 on BIOTIME INC|
Txns:
| Acquired 200,000 options to buy
@ $4.22, valued at
$844k
|
|
| 05/31/2012 |
4
| WEST MICHAEL D (CEO) has filed a Form 4 on BIOTIME INC|
Txns:
| Bought 10,000 shares
@ $4.049, valued at
$40.5k
|
|
| 04/26/2012 |
4
| WEST MICHAEL D (CEO) has filed a Form 4 on BIOTIME INC|
Txns:
| Exercised 20,000 options to buy
@ $0.74, valued at
$14.8k
|
|
| 06/23/2011 |
4
| WEST MICHAEL D (CEO) has filed a Form 4 on BIOTIME INC|
Txns:
| Bought 10,000 shares
@ $4.3962, valued at
$44k
|
|
| 01/05/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/23/2010 |
4
| WEST MICHAEL D (CEO) has filed a Form 4 on BIOTIME INC|
Txns:
| Exercised 20,000 options to buy
@ $1.26, valued at
$25.2k
|
|
| 02/16/2010 |
5
| WEST MICHAEL D (CEO) has filed a Form 5 on BIOTIME INC |
|